Session 11: Urological Cancers - Prostate Cancer Flashcards
Epidemiology of prostate cancer.
Most common cancer in men
2nd most common cause of death from cancer in men.
1 in 8 will be diagnosed in their lifetime
Incidence is increasing
Rare in men aged <50
Nearly every man in their 80s have prostate cancer
Risk factors of prostate cancer
Increasing age
Family history (4x)
BRCA2 gene mutation
Black>white>asian
Type of screening of prostate cancer.
Not mass population but opportunistic meaning that if you come in with associated symptoms you can be screened for.
If you come in to discuss about a family member who has prostate cancer or because they have read about the test.
What kind of test is screening for prostate cancer?
PSA (prostate specific antigen) blood test
Issues for PSA screening
Over-diagnosis
Over-treatment
Cost-effectiveness
Other causes of raised PSA
Having a normal PSA does not mean you do not have prostate cancer.
Give other causes of raised PSA
Infection
Inflammation
Large prostate
Urinary retention
Examination of prostate cancer
DRE
Clinical presentation of prostate cancer
Urinary symptoms
Bone pain
Change in bowel habits
How might prostate cancer be diagnosed.
Had PSA check and then biopsy
Incidental finding at transurethral resection of prostate (TURP)
DRE
Factors influencing treatment of prostate cancer
Age
DRE (whether it is localised, locally advanced or advanced)
PSA levels are important (very high levels rules out treatment)
Biopsies like gleason grade
MRI scan and bone scan to assess grade by nodal and visceral metastases
Treatment of localised prostate cancer
Surveillance
Robotic radical prostatectomy
Radiotherapy
Treatment of locally advanced prostate cancer
Surveillance
Hormones
Hormones and radiotherapy
How does bone metastases relate to PSA levels.
It is very unlikely to have metastasised if PSA levels are below 10ng/ml
Function of bone metastases from prostate cancer.
They are sclerotic aka osteoblastic
Compared to most bone metastases which are the opposite
Treatment of metastatic prostate cancer
Hormones +/- chemotherapy.
Surgical castration
Medical castration via LHRH agonists
Palliation - Radiotherapy and chemotherapy